Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.

  • Martín Ruiz Valdepeñas, María Asunción
  • Fiuza Luces, C.
  • Rincón Castanedo, C.
  • Fernández Moreno, D.
  • González Gálvez, Beatriz
  • Martínez Martínez, Ernesto
  • Martín Acosta, P.
  • Coronado, M. J.
  • Franco Luzón, L.
  • González Murillo, A.
  • Ramírez, M.
  • Provencio, M.
  • Lucia, A.
Background: Lung cancer has the highest incidence and mortality rate in the world. One of the most promising new cancer therapies in recent years is immunotherapy, which is based on the blockade of immune checkpoints such as programmed cell death protein 1 (PD-1). Exercise training is beneficial to maintain and improve the quality of life of cancer patients, and it might also modulate the anti-tumoral efficiency of some chemotherapeutic agents. However, the potential of exercise combined with immunotherapy as a cancer therapy remains to be elucidated. Here, we examined the effects of exercise on tumor growth and its possible adjuvant effects when combined with anti-PD-1 immunotherapy (nivolumab) in a patient derived xenograft (PDX) model of non-small-cell lung carcinoma (NSCLC). Methods: We generated a PDX model using NOD-SCID gamma mice with subcutaneous grafts from tumor tissue of a patient with NSCLC. Animals were randomly assigned to one of four groups: non-exercise + isotype control (n=5), exercise + isotype control (n=5), non-exercise + nivolumab (n=6) or exercise + nivolumab (n=6). The animals undertook an 8- week moderate-intensity training regimen (treadmill aerobic exercise and strength training). Immunotherapy (nivolumab) or an isotype control was administered 2 days/week, for 6 weeks. Several tumor growth and microenvironment parameters were measured after the intervention. Results: Improvements in aerobic capacity and muscle strength (p=0.027 and p=0.005) were noted in exercised animals. Exercise alone reduced the tumor growth rate with respect to non-exercised mice (p=0.050). The double intervention (exercise + nivolumab) increased tumor necrosis and reduced apoptosis with respect to controls (p=0.026; p=0.030). All interventions achieved a reduction in proliferation compared with the control group (p=0.015, p=0.011, and p=0.011). Exercise alone increased myeloid tumor infiltrates (mostly neutrophils) with respect to the nivolumab only group (p=0.018). Finally, Vegf-a expression was higher in the nivolumab groups (in combination or not with exercise) than in exercise + isotype control group (p=0.045 and p=0.047, respectively). No other significant effects were found. Conclusions: Our results would suggest that aerobic and strength training should be studied as an adjuvant to cancer immunotherapy treatment.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Blastocystis occurrence and subtype diversity in European wild boar (Sus scrofa) from the Iberian Peninsula

  • Köster, Pamela C.|||0000-0001-5963-8824
  • Figuereido, Ana M.
  • Maloney, Jenny G.|||0000-0002-6405-883X
  • Dashti, Alejandro|||0000-0001-8707-5731
  • Bailo, Begoña|||0000-0002-9453-9431
  • Tinoco Torres, Rita|||0000-0003-4570-459X
  • Fonseca, Carlos|||0000-0001-6559-7133
  • Mysterud, Atle|||0000-0001-8993-7382
  • Habela, Miguel Ángel
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • Vicente, Joaquín|||0000-0001-8416-3672
  • Serrano Ferron, Emmanuel|||0000-0002-9799-9804
  • Arnal, Maria C.|||0000-0002-6770-3400
  • Fernández de Luco, Daniel|||0000-0003-3289-4267
  • Armenteros, José A.|||0000-0001-8776-1299
  • Balseiro, Ana|||0000-0002-5121-7264
  • Cardona, Guillermo A.|||0000-0002-4156-4174
  • Carvalho, João|||0000-0002-3166-450X
  • Hipólito, Dário|||0000-0002-2985-1314
  • Fernandes, Joana M.|||0000-0001-5602-1490
  • Palmeira, Josman Dantas
  • Calero-Bernal, Rafael|||0000-0003-2323-0135
  • González-Barrio, David|||0000-0001-5083-8854
  • Santín, Mónica
  • Carmena, David|||0000-0002-4015-8553
The ongoing increase in wild boar populations across Europe has fostered human-wildlife conflicts, including the transmission of emerging pathogens with zoonotic importance. Blastocystis is a ubiquitous, faecal-oral transmitted protist that can cause gastrointestinal illnesses and is observed in humans and animals worldwide. The role of wildlife in the epidemiology of Blastocystis is insufficiently understood. Thus, we investigated the occurrence and subtype diversity of Blastocystis in free-ranging wild boars from the Iberian Peninsula using conventional PCR and next-generation amplicon sequencing of a fragment of the ssu RNA gene. A total of 459 wild boar faecal samples were collected across Spain (n = 360) and Portugal (n = 99) between 2014 and 2021. Blastocystis was present in 15.3% (70/459; 95% CI 12.1-18.9) of the wild boars analysed, and its occurrence was significantly higher in Portugal (34.3%, 34/99; 95% CI 25.1-44.6) than in Spain (10.0%, 36/360; 95% CI 7.1-13.6). Seven Blastocystis subtypes (ST5, ST10b, ST13-ST15, ST24b, and ST43) were detected among the surveyed wild boar populations, with greater variability detected in Portuguese samples. ST5 was identified in all the Blastocystis-positive animals, whereas 14.3% of them harboured ST mixed colonisations. Our results demonstrate that Blastocystis ST5 is particularly adapted to infect wild boars. The additional identification of zoonotic STs reinforces the role of wild boars as spreaders of zoonotic infections with public health significance.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Validation of the virtual reality functional capacity assessment tool (VRFCAT) in a Spanish sample of individuals with psychosis and healthy controls

  • González-Blanch, César|||0000-0002-3181-4731
  • López-Carrilero, Raquel|||0000-0003-4110-794X
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Catalan, Ana|||0000-0002-0418-7904
  • Aymerich, Claudia|||0000-0003-0040-1608
  • Rodriguez-Jimenez, Roberto|||0000-0003-2251-7249
  • Gutiérrez-Zotes, Alfonso|||0000-0002-4858-1487
  • Díaz-Mandado, Olimpia
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Cano-Escalera, Guillermo
  • Zubia, Marta
  • Guinart, Daniel
  • del-Castillo-Serrano, Manuel
  • Vilella, Elisabet|||0000-0002-1887-5919
  • García-Álvarez, Leticia
  • Ochoa, Susana|||0000-0001-6792-1080
  • Correa-Ghisays, Patricia|||0000-0002-1752-7349
  • Balanzá-Martínez, Vicent|||0000-0001-7772-7396
  • Vicent Sánchez-Ortí, Joan|||0000-0002-8209-6688
  • Pousa Tomàs, Esther|||0000-0003-4423-6739
  • Miret, Salvador|||0000-0002-2275-8272
  • Falip, Cristina
  • Reguera-Pozuelo, Pablo
  • Fernández-Martínez, Rafael|||0000-0002-0842-898X
  • García-Cabeza, Ignacio|||0000-0002-7542-4321
  • Campos-Rodriguez, Carlos|||0000-0002-6982-1339
  • Crosas Armengol, Josep Maria|||0000-0002-0734-2957
  • Cobo Gomez, Jesus Vicente|||0000-0002-2032-9343
  • Pardina-Torner, Helena|||0000-0002-0720-3412
  • Perona-Garcelán, Salvador|||0000-0002-7771-7857
  • Muñoz-Caracuel, Manuel|||0000-0003-1667-5646
  • Yorca-Ruiz, Ángel|||0000-0002-2701-3755
  • Ortiz García de la Foz, Víctor|||0000-0002-0627-1827
  • Ayesa-Arriola, Rosa|||0000-0003-0570-5352
The Virtual Reality Functional Capacity Assessment Tool (VRFCAT) is a performance-based measure developed to assess functional capacity through simulations of daily activities. This study examined its psychometric properties in a Spanish sample, including individuals with first-episode psychosis (FEP), schizophrenia, and healthy controls. A total of 370 participants (99 FEP, 116 schizophrenia, and 155 controls) completed the VRFCAT in a multicenter study. Internal consistency (McDonald's omega), discriminative validity (group comparisons and ROC curves), and convergent validity via correlations with cognitive performance and clinical symptoms were examined. Reference percentiles were calculated from the healthy control sample using quantile regression, stratified by age and education. Item-level VRFCAT completion times showed acceptable to good internal consistency overall and in controls and schizophrenia samples, but poor in FEP. Differences in VRFCAT performance emerged (χ 2 = 108.88, p.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mutant PRPF8 Causes Widespread Splicing Changes in Spliceosome Components in Retinitis Pigmentosa Patient iPSC-Derived RPE Cells

  • Arzalluz-Luque, Ángeles
  • Cabrera, Jose Luis
  • Skottman, Heli
  • Benguria, Alberto
  • Bolinches-Amorós, Arantxa
  • Cuenca, Nicolás
  • Lupo, Vincenzo
  • Dopazo, Ana
  • Delás, Bárbara
  • Carballo, Miguel
  • Pascual, Beatriz
  • Hernán, Imma
  • Erceg, Slaven
  • Lukovic, Dunja
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Retinitis pigmentosa (RP) is a rare, progressive disease that affects photoreceptors and retinal pigment epithelial (RPE) cells with blindness as a final outcome. Despite high medical and social impact, there is currently no therapeutic options to slow down the progression of or cure the disease. The development of effective therapies was largely hindered by high genetic heterogeneity, inaccessible disease tissue, and unfaithful model organisms. The fact that components of ubiquitously expressed splicing factors lead to the retina-specific disease is an additional intriguing question. Herein, we sought to correlate the retinal cell-type-specific disease phenotype with the splicing profile shown by a patient with autosomal recessive RP, caused by a mutation in pre-mRNA splicing factor 8 (PRPF8). In order to get insight into the role of PRPF8 in homeostasis and disease, we capitalize on the ability to generate patient-specific RPE cells and reveal differentially expressed genes unique to RPE cells. We found that spliceosomal complex and ribosomal functions are crucial in determining cell-type specificity through differential expression and alternative splicing (AS) and that PRPF8 mutation causes global changes in splice site selection and exon inclusion that particularly affect genes involved in these cellular functions. This finding corroborates the hypothesis that retinal tissue identity is conferred by a specific splicing program and identifies retinal AS events as a framework toward the design of novel therapeutic opportunities., This work was supported by Institute of Health Carlos III/ERDF (European Regional Development Fund), Spain [PI16/00409 (DL), PI20/01119 (DL), CP18/00033 (DL), PI15/00227 (MC), CPII16/00037 (SE), and PI18-00286 (SE)], Platform for Proteomics, Genotyping and Cell Lines; PRB3 of ISCIII (PT17/0019/0024); National Science Foundation GACR 18-04393S and the project "Centre of Reconstructive Neuroscience", registration number CZ.02.1.01/0.0./0.0/15_003/0000419PI15/00227; Spanish Ministry of Economy and Competitiveness grant BES-2016-076994 (AA-L); and Academy of Finland (HS).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Plasma fibroblast activation protein is decreased in acute heart failure despite cardiac tissue upregulation

  • Delgado-Arija, Marta
  • Genovés, Patricia
  • Pérez-Carrillo, Lorena
  • González-Torrent, Irene
  • Giménez-Escamilla, Isaac
  • Martínez-Dolz, Luis
  • Portolés, Manuel
  • Tarazón, Estefanía
  • Roselló-Lletí, Esther
[EN] Background Cardiac fibroblast activation protein (FAP) has an emerging role in heart failure (HF). A paradoxical reduction in its levels in pathological conditions associated with acute processes has been observed. We aimed to identify FAP cardiac tissue expression and its relationship with the main cardiac fibrosis-related signaling pathways, and to compare plasma FAP levels in acute and chronic HF patients. Methods Transcriptomic changes were assessed via mRNA/ncRNA-seq in left ventricle tissue from HF patients (n¿=¿57) and controls (n¿=¿10). Western blotting and immunohistochemistry were used to explore FAP protein levels and localization in cardiac tissue. ELISA was performed to examine plasma FAP levels in acute HF (n¿=¿48), chronic HF (n¿=¿15) and control samples (n¿=¿7). Results FAP overexpression in cardiac tissue is related to the expression of molecules directly involved in cardiac fibrosis, such as POSTN, THBS4, MFAP5, COL1A2 and COL3A1 (P¿<¿0.001), and is directly and inversely related to pro- and antifibrotic microRNAs, respectively. The observed FAP overexpression is not reflected in plasma. Circulating FAP levels were lower in acute HF patients than in controls (P¿<¿0.05), while chronic HF patients did not show significant changes. The clinical variables analyzed, such as functional class or etiology, do not affect plasma FAP concentrations. Conclusions We determined that in HF cardiac tissue, FAP is related to the main cardiac fibrosis signaling pathways as well as to pro- and antifibrotic microRNAs. Additionally, an acute phase of HF decreases plasma FAP levels despite the upregulation observed in cardiac tissue and regardless of other clinical conditions., This work was supported by the National Institute of Health Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III [Projects: PI20/01469 and PI20/00071 co-funded by European Union; Miguel Servet contracts: CP18/00145 co-funded by European Union, European Social Fund (ESF) The ESF invests in your future and CP21/00041 co-funded by European Union; contract FI21/00186 and FI21/00034]; Consorcio Centro de Investi&#8209; gación Biomédica en Red [CIBERCV, under Grant CB16/11/00261]; Ministry of Universities and the European Recovery, Transformation and Resilience Plan (PRTR, Next Generation EU) [ Ayuda Margarita Salas para la formación de jóvenes doctores : contract: MS21-162]; Ministry of Science and Innovation (MCIN, 10.13039/501100011033) and State Investigation Agency (AEI) [Project CNS2022-135769] co-funded by European Union Next Generation EU and PRTR; Conselleria de educación, universidades y empleo [Project CIA&#8209; ICO/2022/246, contract CIACIF/2022/429].
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publication Artículo científico (JournalArticle)

Exercise Training and Natural Killer Cells in Cancer Survivors: Current Evidence and Research Gaps Based on a Systematic Review and Meta-analysis

  • Valenzuela, Pedro L.
  • Saco-Ledo, Gonzalo
  • Santos-Lozano, Alejandro
  • Morales Rojas, JavierSalvador
  • Castillo-García, Adrián
  • Simpson, Richard J.
  • Lucia, Alejandro
  • Fiuza-Luces, Carmen
Background: Exercise training can positively impact the immune system and particularly natural killer (NK) cells, at least in healthy people. This effect would be of relevance in the context of cancer given the prominent role of these cells in antitumor immunity. In this systematic review and meta-analysis, we aimed to summarize current evidence on the effects of exercise training on the levels and function of NK cells in cancer survivors (i.e., from the time of diagnosis until the end of life). Methods: Relevant articles were searched in PubMed, Scopus, Web of Science and Cochrane Central Register of Controlled Trials (until January 11, 2022). Randomized controlled trials (RCT) of exercise training (i.e., non-acute) interventions vs usual care conducted in cancer survivors and assessing NK number and/or cytotoxic activity (NKCA) before and upon completion of the intervention were included. Methodological quality of the studies was assessed with the PEDro scale, and results were meta-analyzed using a random effects (Dersimoian and Laird) model. Results: Thirteen RCT including 459 participants (mean age ranging 11-63 years) met the inclusion criteria. Methodological quality of the studies was overall fair (median PEDro score = 5 out of 10). There was heterogeneity across studies regarding cancer types (breast cancer, non-small cell lung cancer and other solid tumors), treatment (e.g., receiving vs having received chemotherapy), exercise modes (aerobic or resistance exercise, Tai Chi, Yoga) and duration (2-24 weeks). No consistent effects were observed for NK number in blood (mean difference [MD]: 1.47, 95% confidence interval [CI] - 0.35 to 3.29, p = 0.113) or NKCA as assessed in vitro (MD: - 0.02, 95%CI - 0.17 to 0.14, p = 0.834). However, mixed results existed across studies, and some could not be meta-analyzed due to lack of information or methodological heterogeneity. Conclusions: Current evidence does not support a significant effect of exercise training intervention on NK cells in blood or on their `static response' (as assessed in vitro) in cancer survivors. Several methodological issues and research gaps are highlighted in this review, which should be considered in future studies to draw definite conclusions on this topic., Research in pediatric/adolescent cancer by Alejandro Lucia and Carmen Fiuza-Luces is funded by: 'the Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant program (grant #IIG_ FULL_2021_007), the Spanish Ministry of Science and Innovation (Fondo de Investigaciones Sanitarias [FIS]) and Fondos FEDER (grant numbers PI18/00139 and PI20/00645); the Spanish Ministry of Science and Innovation (Instituto de Salud Carlos III, postdoctoral contract Miguel Servet, #CP18/00034); and by a grant from the National Strength and Conditioning Association (NCSA) Foundation (Grant No. PS.1816).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Histone extraction from human articular cartilage for the study of epigenetic regulation in osteoarthritis

  • Núñez-Carro, Carmen
  • Blanco-Blanco, Margarita
  • Montoya, Tatiana
  • Villagrán-Andrade, Karla Mariuxi
  • Hermida Gómez, Tamara
  • Blanco García, Francisco J
  • Andrés, María C. de
[Abstract] Osteoarthritis (OA) is a chronic disease that affects articular cartilage, causing its degeneration. Although OA is one of the most prevalent pathologies globally, there are no definitive treatments available. Recently, research has focused on elucidating the complex interplay that takes place between inflammatory processes and epigenetic regulation, showing that histone post-translational modifications (PTMs) can exert a pronounced effect on the expression of OA-related genes. OA chondrocytes enhance the production of interleukin 1β (IL-1β) and interleukin 8 (IL-8), which are epigenetically regulated. These cytokines upregulate the synthesis of matrix metalloproteinases (MMPs) and aggrecanases, which promote the extracellular matrix (ECM) destruction. This motivates the study of histone PTMs to investigate the epigenetic regulation of proinflammatory molecules, but the absence of specific protocols to extract histones from human articular cartilage has complicated this task. The lack of effective methods can be explained by the structural complexity and low cellularity of this tissue, which are responsible for the biomechanical properties that allow the movement of the joint but also complicate histone isolation. Here, we provide a histone extraction procedure specifically adapted for cryopreserved human articular cartilage that can be useful to understand epigenetic regulation in OA and accelerate the search for novel strategies., This research was funded by Instituto de Salud Carlos III (grant No. PI19/01213 and grant No. RD21/0002/0009), integrated in the National Plan for Scientific Research, Development and Technological Innovation 2017–2020 and funded by the ISCIII —General Subdirection of Assessment and Promotion of the Research—European Regional Development Fund (FEDER) “A way of making Europe”. M.C.D.A is supported by the Miguel Servet program from Fondo Investigación Sanitaria-Spain (CP18/00084). Also, by Xunta de Galicia (grant No. IN607A 2021/7). The Biomedical Research Networking Center (CIBER) is an initiative from Instituto de Salud Carlos III (ISCIII), Xunta de Galicia; IN607A 2021/7
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

  • Pérez-Nadales, E.
  • Alastruey-Izquierdo, A.
  • Linares-Sicilia, M.J.
  • Soto-Debrán, J.C.
  • Abdala, E.
  • García-Rodríguez, J.
  • Montejo, M.
  • Muñoz, P.
  • Lletí, M.S.
  • Rezusta, A.
  • de Pipaón, M.R.P.
  • Yáñez, L.
  • Merino, E.
  • Campos-Herrero, M.I.
  • Costa-Mateo, J.M.
  • Fortún, J.
  • García-Lozano, T.
  • Garcia-Vidal, C.
  • Fernández-Ruiz, M.
  • Sánchez-Reus, F.
  • Castro-Méndez, C.
  • Guerrero-Lozano, I.
  • Soler-Palacín, P.
  • Aguado, J.M.
  • Martínez-Martínez, L.
  • Torre-Cisneros, J.
  • Nucci, M.
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 339.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Blastocystis occurrence and subtype diversity in European wild boar (Sus scrofa) from the Iberian Peninsula

  • Köster, Pamela C.
  • Figueiredo, Ana M.
  • Maloney, Jenny G.
  • Dashti, Alejandro
  • Bailo, Begoña
  • Torres, Rita T.
  • Fonseca, Carlos
  • Mysterud, Atle
  • Habela, Miguel Á.
  • Rivero-Juarez, Antonio
  • Vicente, Joaquín
  • Serrano, Emmanuel
  • Arnal, Maria C.
  • de Luco, Daniel Fernández
  • Armenteros, José A.
  • Balseiro, Ana
  • Cardona, Guillermo A.
  • Carvalho, João
  • Hipólito, Dário
  • Fernandes, Joana
  • Palmeira, Josman D.
  • Calero-Bernal, Rafael
  • González-Barrio, David
  • Santin, Monica
  • Carmena, David
The ongoing increase in wild boar populations across Europe has fostered human–wildlife conflicts, including the transmission of emerging pathogens with zoonotic importance. Blastocystis is a ubiquitous, faecal-oral transmitted protist that can cause gastrointestinal illnesses and is observed in humans and animals worldwide. The role of wildlife in the epidemiology of Blastocystis is insufficiently understood. Thus, we investigated the occurrence and subtype diversity of Blastocystis in free-ranging wild boars from the Iberian Peninsula using conventional PCR and next-generation amplicon sequencing of a fragment of the ssu RNA gene. A total of 459 wild boar faecal samples were collected across Spain (n = 360) and Portugal (n = 99) between 2014 and 2021. Blastocystis was present in 15.3% (70/459; 95% CI 12.1–18.9) of the wild boars analysed, and its occurrence was significantly higher in Portugal (34.3%, 34/99; 95% CI 25.1–44.6) than in Spain (10.0%, 36/360; 95% CI 7.1–13.6). Seven Blastocystis subtypes (ST5, ST10b, ST13–ST15, ST24b, and ST43) were detected among the surveyed wild boar populations, with greater variability detected in Portuguese samples. ST5 was identified in all the Blastocystis-positive animals, whereas 14.3% of them harboured ST mixed colonisations. Our results demonstrate that Blastocystis ST5 is particularly adapted to infect wild boars. The additional identification of zoonotic STs reinforces the role of wild boars as spreaders of zoonotic infections with public health significance.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition

  • Rodiño Janeiro, Bruno Kotska
  • Khannous, Olfat
  • Pigrau Pastor, Marc
  • Willis, Jesse R.
  • Pardo Camacho, Cristina
  • Albert Bayo, Mercé
  • Martínez Martínez, Cristina
  • lobo, beatriz
  • Santos, Javier
  • Salvo Romero, Eloisa
  • Nieto Ruiz, Adoración
  • Expósito , Elba
  • Fortea, Marina
  • González Castro, Ana Maria
  • Guagnozzi, Danila
  • Vicario Perez, Maria
  • Alonso Cotoner, Carmen
Irritable bowel syndrome; Small intestine microbiota; Stress, Síndrome del intestino irritable; Microbiota del intestino delgado; Estrés, Síndrome de l'intestí irritable; Microbiota de l'intestí prim; Estrès, Background/aims: Digestive disorders of gut-brain interaction (DGBI) are very common, predominant in females, and usually associated with intestinal barrier dysfunction, dysbiosis, and stress. We previously found that females have increased susceptibility to intestinal barrier dysfunction in response to acute stress. However, whether this is associated with changes in the small bowel microbiota remains unknown. We have evaluated changes in the small intestinal microbiota in response to acute stress to better understand stress-induced intestinal barrier dysfunction. Methods: Jejunal biopsies were obtained at baseline and 90 min after cold pain or sham stress. Autonomic (blood pressure and heart rate), hormonal (plasma cortisol and adrenocorticotropic hormone) and psychological (Subjective Stress Rating Scale) responses to cold pain and sham stress were monitored. Microbial DNA from the biopsies was analyzed using a 16S metabarcoding approach before and after cold pain stress and sham stress. Differences in diversity and relative abundance of microbial taxa were examined. Results: Cold pain stress was associated with a significant decrease in alpha diversity (P = 0.015), which was more pronounced in females, along with significant sex differences in the abundance of specific taxa and the overall microbiota composition. Microbiota alterations significantly correlated with changes in psychological responses, hormones, and gene expression in the intestinal mucosal. Cold pain stress was also associated with activation of autonomic, hormonal and psychological response, with no differences between sexes. Conclusions: Acute stress elicits rapid alterations in bacterial composition in the jejunum of healthy subjects and these changes are more pronounced in females. Our results may contribute to the understanding of female predominance in DGBI., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Fondo Europeo de Desarrollo Regional (FEDER), Fondo de Investigación Sanitaria and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), y de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad y Ministerio de Ciencia e Innovación: EII2011-0035, CD15/00010 and MV17-00043 (BR-J); CM10/00155 (MP); FI12/00254 (ES-R); FI20/00256 (MA-B); CP18/00116 (CM); PI19/01643 (BL); PI16/00583, PI19/01643 and CPII16/00031 (MV); PI17/0190 (JS); INB Grant PT17/0009/0023 (TG); PI15/00301 (CA-C); CIBEREHD CB06/04/0021 (AG-C, DG, BL, MV, JS, CA-C); CIBERINFEC CB21/13/00061 (TG). Vall d'Hebron Institut de Recerca, Programa de becas predoctorales Amics de Vall d'Hebron: PRED-VHIR-2014-018 (MF), PRED-VHIR-2016-53 (CP-C). Ajuts per a la contractació de personal investigador FI, Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya: 2020FI_B1 00127 & 2019FI_B 00817 (MA-B), SGR423 (TG). Formación de profesorado universitario (FPU) program from the Spanish Ministerio de Universidades: FPU2020-02907 (OK-L). European Union's Horizon 2020 research and innovation program: ERC-2016-724173 (TG). Gordon and Betty Moore Foundation: GBMF9742 (TG).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome

  • Roca, Neus
  • Jatem-Escalante, Elias
  • Martin, Maria Luisa
  • Muñoz López, Marina
  • Molina, Maria
  • Martínez, Cristina
Biomarcadors; Activació endotelial; Síndrome nefròtica, Biomarcadores; Activación endotelial; Síndrome nefrótico, Biomarkers; Endothelial activation; Nephrotic syndrome, Background Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR constitutes a predictor of vascular disease and has been associated with endothelial dysfunction, we hypothesized that suPAR levels are related to endothelial activation or dysfunction in INS patients. The aims of this study were to evaluate the relationship between serum concentrations of endothelial biomarkers and suPAR in patients with different histological patterns of INS and healthy controls, and to determine the demographic, clinical and biochemical characteristics of INS patients that influence suPAR serum levels. Methods This observational, cross-sectional study included patients with INS, diagnosed with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS) or membranous nephropathy (MN) by renal biopsy. Patient demographic, clinical and biochemical characteristics were recorded and blood samples were obtained at the time of diagnosis. Measurements of suPAR and endothelial molecules via serum levels were performed using Enzyme-Linked ImmunoSorbent Assay kits. Results Patients with nephrotic syndrome (n = 152) caused by FSGS, MCD or MN had increased circulating levels of endothelial markers. suPAR levels positively correlated with age and the serum levels of almost all endothelial markers. Generally, endothelial cell molecules positively correlated with each other. suPAR levels were not associated with the histopathological pattern of INS. Conclusions In patients with INS secondary to FSGS, MCD and NM, circulating levels of suPAR are independent of the primary renal disease, and significantly associated with age, glomerular filtration rate and the levels of various endothelial markers., C.M. is supported by a Miguel Servet grant, Fondo de investigación sanitaria, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, CP18/00116. No additional funding was required in the development of the current study
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome

  • Lleó, Alberto|||0000-0002-2568-5478
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Fernández, Susana|||0000-0002-9777-1156
  • Benejam, Bessy|||0000-0002-6789-8615
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Xiao, Mei-Fang
  • Xu, Desheng
  • Núñez-Llaves, Raúl|||0000-0002-6702-4774
  • Querol-Vilaseca, Marta|||0000-0002-8589-1636
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Blesa, Rafael|||0000-0003-4026-2884
  • Worley, Paul
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Fortea, Juan|||0000-0002-1340-638X
  • Belbin, Olivia|||0000-0002-6109-6371
There is an urgent need for objective markers of Alzheimer's disease (AD)-related cognitive impairment in people with Down syndrome (DS) to improve diagnosis, monitor disease progression, and assess response to disease-modifying therapies. Previously, GluA4 and neuronal pentraxin 2 (NPTX2) showed limited potential as cerebrospinal fluid (CSF) markers of cognitive impairment in adults with DS. Here, we compare the CSF profile of a panel of synaptic proteins (Calsyntenin-1, Neuroligin-2, Neurexin-2A, Neurexin-3A, Syntaxin-1B, Thy-1, VAMP-2) to that of NPTX2 and GluA4 in a large cohort of subjects with DS across the preclinical and clinical AD continuum and explore their correlation with cognitive impairment. We quantified the synaptic panel proteins by selected reaction monitoring in CSF from 20 non-trisomic cognitively normal controls (mean age 44) and 80 adults with DS grouped according to clinical AD diagnosis (asymptomatic, prodromal AD or AD dementia). We used regression analyses to determine CSF changes across the AD continuum and explored correlations with age, global cognitive performance (CAMCOG), episodic memory (modified cued-recall test; mCRT) and CSF biomarkers, CSF Aβ ratio, CSF Aβ, CSF p-tau, and CSF NFL. P values were adjusted for multiple testing. In adults with DS, VAMP-2 was the only synaptic protein to correlate with episodic memory (delayed recall adj.p =.04) and age (adj.p =.0008) and was the best correlate of CSF Aβ (adj.p =.0001), p-tau (adj.p < .0001), and NFL (adj.p < .0001). Compared to controls, mean VAMP-2 levels were lower in asymptomatic adults with DS only (adj.p =.02). CSF levels of Neurexin-3A, Thy-1, Neurexin-2A, Calysntenin-1, Neuroligin-2, GluA4, and Syntaxin-1B all strongly correlated with NPTX2 (p <.0001), which was the only synaptic protein to show reduced CSF levels in DS at all AD stages compared to controls (adj.p <.002). These data show proof-of-concept for CSF VAMP-2 as a potential marker of synapse degeneration that correlates with CSF AD and axonal degeneration markers and cognitive performance.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Perspectives of Patients with Chronic Diseases and Their Caregivers on Self-Management Interventions, A Scoping Review of Reviews

  • Niño de Guzmán, Ena Pery|||0000-0001-6587-2780
  • Martínez García, Laura|||0000-0003-0126-8706
  • Orrego, Carola|||0000-0002-2978-6268
  • Heijmans, Monique|||0000-0003-2266-3596
  • Suñol Sala, Rosa|||0000-0003-1902-833X
  • Fraile Navarro, David
  • Pérez Bracchiglione, Javier Andrés|||0000-0001-8738-2184
  • Ninov, Lyudmil
  • Salas-Gama, Karla|||0000-0003-4845-4899
  • Viteri-García, A.|||0000-0003-0393-2404
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Self-management (SM) interventions are supportive interventions systematically provided by healthcare professionals, peers, or laypersons to increase the skills and confidence of patients in their ability to manage chronic diseases. We had two objectives: (1) to summarise the preferences and experiences of patients and their caregivers (informal caregivers and healthcare professionals) with SM in four chronic diseases and (2) to identify and describe the relevant outcomes for SM interventions from these perspectives. We conducted a mixed-methods scoping review of reviews. We searched three databases until December 2020 for quantitative, qualitative, or mixed-methods reviews exploring patients' and caregivers' preferences or experiences with SM in type 2 diabetes mellitus (T2DM), obesity, chronic obstructive pulmonary disease (COPD), and heart failure (HF). Quantitative data were narratively synthesised, and qualitative data followed a three-step descriptive thematic synthesis. Identified themes were categorised into outcomes or modifiable factors of SM interventions. We included 148 reviews covering T2DM (n = 53 [35.8%]), obesity (n = 20 [13.5%]), COPD (n = 32 [21.6%]), HF (n = 38 [25.7%]), and those with more than one disease (n = 5 [3.4%]). We identified 12 main themes. Eight described the process of SM (disease progression, SM behaviours, social support, interaction with healthcare professionals, access to healthcare, costs for patients, culturally defined roles and perceptions, and health knowledge), and four described their experiences with SM interventions (the perceived benefit of the intervention, individualised care, sense of community with peers, and usability of equipment). Most themes and subthemes were categorised as outcomes of SM interventions. The process of SM shaped the perspectives of patients and their caregivers on SM interventions. Their perspectives were influenced by the perceived benefit of the intervention, the sense of community with peers, the intervention's usability, and the level of individualised care. Our findings can inform the selection of patient-important outcomes, decision-making processes, including the formulation of recommendations, and the design and implementation of SM interventions.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Toolkit of methodological resources to conduct systematic reviews

  • Roqué i Figuls, Marta|||0000-0003-0043-1364
  • Martínez García, Laura|||0000-0003-0126-8706
  • Solà Arnau, Ivan|||0000-0003-0078-3706
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
  • Bonfill, X. (Xavier)|||0000-0003-1530-3509
  • Zamora, Javier|||0000-0003-4901-588X
Background: Systematic reviews (SR) can be classified by type depending on the research question they are based on. This work identifies and describes the most relevant methodological resources to conduct high-quality reviews that answer health care questions regarding prevalence, prognosis, diagnostic accuracy and effects of interventions. Methods: Methodological resources have been identified from literature searches and consulting guidelines from institutions that develop SRs. The selected resources are organized by type of SR, and stage of development of the review (formulation of the research question, development of the protocol, literature search, risk of bias assessment, synthesis of findings, assessment of the quality of evidence, and report of SR results and conclusions). Results: Although the different types of SRs are developed following the same steps, each SR type requires specific methods, differing in characteristics and complexity. The extent of methodological development varies by type of SR, with more solid guidelines available for diagnostic accuracy and effects of interventions SRs. This methodological toolkit describes the most up-to-date risk of bias instruments: Quality in Prognostic Studies (QUIPS) tool and Prediction model study Risk Of Bias Assessment Tool (PROBAST) for prognostic SRs, Quality assessment of diagnostic accuracy studies tool (QUADAS-2) for diagnostic accuracy SRs, Cochrane risk of bias tool (ROB-2) and Risk of bias in non-randomised studies of interventions studies tool (ROBINS-I) for effects of interventions SRs, as well as the latest developments on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Conclusions : This structured compilation of the best methodological resources for each type of SR may prove to be a very useful tool for those researchers that wish to develop SRs or conduct methodological research works on SRs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

  • Salvo-Romero, Eloísa
  • Martínez, Cristina|||0000-0002-9368-1356
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Sánchez Chardi, Alejandro|||0000-0002-8789-1883
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Fortea, Marina|||0000-0001-8885-7495
  • Pardo-Camacho, Cristina
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Expósito, Elba|||0000-0001-6088-3149
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Farré, Ricard|||0000-0001-7158-171X
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • Vicario Perez, Maria|||0000-0001-9622-3185
Corticotropin-releasing factor (CRF) has been identified in intestinal mucosal eosinophils and associated with psychological stress and gut dysfunction. Irritable bowel syndrome (IBS) is commonly characterized by altered intestinal motility, immune activation, and increased gut barrier permeability along with heightened susceptibility to psychosocial stress. Despite intensive research, the role of mucosal eosinophils in stress-associated gut dysfunction remains uncertain. In this study, we evaluated eosinophil activation profile and CRF content in the jejunal mucosa of diarrhea-predominant IBS (IBS-D) and healthy controls (HC) by gene/protein expression and transmission electron microscopy. We also explored the association between intestinal eosinophil CRF and chronic stress, and the potential mechanisms underlying the stress response by assessing eosinophil response to neuropeptides. We found that mucosal eosinophils displayed higher degranulation profile in IBS-D as compared to HC, with increased content of CRF in the cytoplasmic granules, which significantly correlated with IBS clinical severity, life stress background and depression. Eosinophils responded to substance P and carbachol by increasing secretory activity and CRF synthesis and release, without promoting pro-inflammatory activity, a profile similar to that found in mucosal eosinophils from IBS-D. Collectively, our results suggest that intestinal mucosal eosinophils are potential contributors to stress-mediated gut dysfunction through CRF production and release.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The perspectives of patients and their caregivers on self-management interventions for chronic conditions, a protocol for a mixed-methods overview

  • Niño de Guzmán, Ena Pery|||0000-0001-6587-2780
  • Martínez García, Laura|||0000-0003-0126-8706
  • González, Ana I.
  • Heijmans, Monique|||0000-0003-2266-3596
  • Huaringa, Jorge
  • Immonen, Kaisa
  • Ninov, Lyudmil
  • Orrego, Carola|||0000-0002-2978-6268
  • Pérez Bracchiglione, Javier Andrés|||0000-0001-8738-2184
  • Salas-Gama, Karla|||0000-0003-4845-4899
  • Viteri-García, A.|||0000-0003-0393-2404
  • Alonso-Coello, Pablo|||0000-0002-8001-8504
Introduction : Self-management (SM) interventions are complex interventions and one of the main components of high-quality chronic disease care for which the incorporation of the perspectives of patients and their informal caregivers is crucial. We aim to identify, appraise and synthesise the evidence exploring patients' and caregivers' perspectives on SM interventions. More precisely, we aim to 1) describe how they value the importance of outcomes of SM interventions, and 2) identify the factors that might impact on acceptability and feasibility of SM interventions based on their preferences and experiences. Methods and analysis : We will conduct four mixed-methods overviews as part of COMPAR-EU, a European Union (EU) funded project aimed to identify the most effective and cost-effective SM interventions for chronic obstructive pulmonary disease (COPD), heart failure (HF), obesity, and type 2 diabetes mellitus (T2DM). We will search in MEDLINE, CINAHL, and PsycINFO for systematic reviews of studies addressing patients' preferences on outcomes, or their experiences with SM alongside their disease trajectory or with SM interventions, published in English. Selection of studies and data extraction will be conducted in pairs. We will assess the overlap of studies and methodological quality. We will follow a three-step synthesis process: 1) narrative synthesis for quantitative evidence, 2) thematic synthesis for qualitative evidence, and 3) integration of findings in the interpretation phase. Additionally, we will consult on the relevance of findings with patients and their caregivers. Systematic review registration : PROSPERO.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of Apolipoprotein e ϵ4 Allele with Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults with down Syndrome

  • Bejanin, Alexandre|||0000-0002-9958-0951
  • Iulita, M. Florencia|||0000-0002-3360-4498
  • Vilaplana, Eduard|||0000-0002-1809-8435
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Benejam, Bessy|||0000-0002-6789-8615
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Fernandez, S.
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Montal, Victor|||0000-0002-5714-9282
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Giménez, Sandra|||0000-0001-8031-2319
  • González-Ortiz, Sofía|||0000-0003-2578-6671
  • Muñoz, Laia|||0000-0003-0578-3094
  • Padilla, Concepción|||0000-0003-4102-6787
  • Aranha, Mateus|||0000-0001-9594-292X
  • Estellés, Teresa
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Belbin, Olivia|||0000-0002-6109-6371
  • Camacho, Valle|||0000-0003-0748-0847
  • Wilson, Liam Reese
  • Annus, Tiina
  • Osorio, R.S.
  • Videla, S.
  • Lehmann, Sylvain|||0000-0001-6117-562X
  • Holland, Anthony|||0000-0003-4107-130X
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Blennow, Kaj|||0000-0002-1890-4193
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Zaman, Shahid
  • Blesa, Rafael|||0000-0003-4026-2884
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
Importance: Alzheimer disease (AD) is the leading cause of death in individuals with Down syndrome (DS). Previous studies have suggested that the APOE ϵ4 allele plays a role in the risk and age at onset of dementia in DS; however, data on in vivo biomarkers remain scarce. Objective: To investigate the association of the APOE ϵ4 allele with clinical and multimodal biomarkers of AD in adults with DS. Design, Setting, and Participants: This dual-center cohort study recruited adults with DS in Barcelona, Spain, and in Cambridge, UK, between June 1, 2009, and February 28, 2020. Included individuals had been genotyped for APOE and had at least 1 clinical or AD biomarker measurement; 2 individuals were excluded because of the absence of trisomy 21. Participants were either APOE ϵ4 allele carriers or noncarriers. Main Outcomes and Measures: Participants underwent a neurological and neuropsychological assessment. A subset of participants had biomarker measurements: Aβ1-42, Aβ1-40, phosphorylated tau 181 (pTau181) and neurofilament light chain (NfL) in cerebrospinal fluid (CSF), pTau181, and NfL in plasma; amyloid positron emission tomography (PET); fluorine 18-labeled-fluorodeoxyglucose PET; and/or magnetic resonance imaging. Age at symptom onset was compared between APOE ϵ4 allele carriers and noncarriers, and within-group local regression models were used to compare the association of biomarkers with age. Voxelwise analyses were performed to assess topographical differences in gray matter metabolism and volume. Results: Of the 464 adults with DS included in the study, 97 (20.9%) were APOE ϵ4 allele carriers and 367 (79.1%) were noncarriers. No differences between the 2 groups were found by age (median [interquartile range], 45.9 [36.4-50.2] years vs 43.7 [34.9-50.2] years; P =.56) or sex (51 male carriers [52.6%] vs 199 male noncarriers [54.2%]). APOE ϵ4 allele carriers compared with noncarriers presented with AD symptoms at a younger age (mean [SD] age, 50.7 [4.4] years vs 52.7 [5.8] years; P =.02) and showed earlier cognitive decline. Locally estimated scatterplot smoothing curves further showed between-group differences in biomarker trajectories with age as reflected by nonoverlapping CIs. Specifically, carriers showed lower levels of the CSF Aβ1-42 to Aβ1-40 ratio until age 40 years, earlier increases in amyloid PET and plasma pTau181, and earlier loss of cortical metabolism and hippocampal volume. No differences were found in NfL biomarkers or CSF total tau and pTau181. Voxelwise analyses showed lower metabolism in subcortical and parieto-occipital structures and lower medial temporal volume in APOE ϵ4 allele carriers. Conclusions and Relevance: In this study, the APOE ϵ4 allele was associated with earlier clinical and biomarker changes of AD in DS. These results provide insights into the mechanisms by which APOE increases the risk of AD, emphasizing the importance of APOE genotype for future clinical trials in DS.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epidemiological survey and risk factors associated with Paslahepevirus balayani in equines in Europe

  • Caballero-Gómez, Javier|||0000-0002-6241-3439
  • Rivero-Juarez, Antonio|||0000-0002-5813-6889
  • Cano-Terriza, David|||0000-0001-5657-2567
  • Fajardo, Tomás
  • Buono, Francesco
  • José Cunilleras, Eduard|||0000-0002-4536-7717
  • García Macías, Jesús
  • Alguacil, Eduardo
  • Rivero Román, Antonio|||0000-0002-8643-4250
  • García Bocanegra, Ignacio|||0000-0003-3388-2604
Paslahepevirus balayani (HEV) is an important emerging zoonotic virus in Europe. Although domestic pigs and wild boar are the main reservoirs of this pathogen, susceptibility to this virus has been confirmed in a growing number of animal species, including equines. However, their role in the epidemiology of this virus remains poorly understood. Our aim was to assess HEV circulation and identify potential risk factors associated with exposure in equid species in different European countries. A total of 596 equines, including 496 horses, 63 donkeys and 37 mules/hinnies bred in four European countries (Spain, Italy, United Kingdom and Ireland) were sampled. Thirty-three animals (5.5%; 95%CI: 3.7-7.4) had anti-HEV antibodies. Seropositivity was found in 4.6% of horses, 11.1% of donkeys and 8.1% of mules/hinnies tested. By country, 6.3%, 5.4%, 5.0% and 4.0% of the equines sampled in Spain, Italy, United Kingdom and Ireland, respectively, were seropositive, respectively. Statistical analysis showed that "species" and "drinking water from ponds and streams" were potential risk factors associated with HEV seropositivity in equines in Europe. HEV RNA was not detected in any (0.0%; 95%CI: 0.0-1.8) of the 202 equines tested. Our results provide evidence of a low, spatially homogeneous and widespread viral circulation that is not equal across species in equid populations in the European countries analyzed and indicate that these species appear to play a limited role in the epidemiology of this virus. Further studies are required to elucidate the differences in seroprevalence between donkeys, mules/hinnies and horses and to determine the risk of zoonotic transmission of this pathogen from equid species.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome, Jejunal Barrier Alterations Underlying Clinical Manifestations

  • Pardo-Camacho, Cristina
  • Ganda Mall, John-Peter|||0000-0002-2120-7743
  • Martínez, Cristina|||0000-0002-9368-1356
  • Pigrau Pastor, Marc|||0000-0001-6801-3017
  • Expósito, Elba|||0000-0001-6088-3149
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • Melón-Ardanaz, Elisa
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Rodiño-Janeiro, Bruno
  • Fortea, Marina|||0000-0001-8885-7495
  • Guagnozzi, Danila|||0000-0002-6171-1901
  • Rodríguez-Urrutia, Amanda|||0000-0001-6882-205X
  • de Torres, Inés|||0000-0002-5495-9140
  • Santos-Briones, Ignacio
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Alonso Cotoner, Carmen|||0000-0002-3483-2919
  • Santos, Javier|||0000-0002-4798-5033
  • González Castro, Ana Maria|||0000-0003-3955-3318
  • Vicario Perez, Maria|||0000-0001-9622-3185
Irritable bowel syndrome (IBS) is a disorder of brain-gut interaction characterised by abdominal pain and changes in bowel habits. In the diarrhoea subtype (IBS-D), altered epithelial barrier and mucosal immune activation are associated with clinical manifestations. We aimed to further evaluate plasma cells and epithelial integrity to gain understanding of IBS-D pathophysiology. One mucosal jejunal biopsy and one stool sample were obtained from healthy controls and IBS-D patients. Gastrointestinal symptoms, stress, and depression scores were recorded. In the jejunal mucosa, RNAseq and gene set enrichment analyses were performed. A morphometric analysis by electron microscopy quantified plasma cell activation and proximity to enteric nerves and glycocalyx thickness. Immunoglobulins concentration was assessed in the stool. IBS-D patients showed differential expression of humoral pathways compared to controls. Activation and proximity of plasma cells to nerves and IgG concentration were also higher in IBS-D. Glycocalyx thickness was lower in IBS-D compared to controls, and this reduction correlated with plasma cell activation, proximity to nerves, and clinical symptoms. These results support humoral activity and loss of epithelial integrity as important contributors to gut dysfunction and clinical manifestations in IBS-D. Additional studies are needed to identify the triggers of these alterations to better define IBS-D pathophysiology.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Eosinophils in the Gastrointestinal Tract, Key Contributors to Neuro-Immune Crosstalk and Potential Implications in Disorders of Brain-Gut Interaction

  • Salvo-Romero, Eloísa
  • Rodiño-Janeiro, Bruno K.|||0000-0002-0633-6774
  • Albert-Bayo, Mercé|||0000-0002-9726-8083
  • Lobo Álvarez, Beatriz|||0000-0003-3391-7125
  • Santos, Javier|||0000-0002-4798-5033
  • Farré, Ricard|||0000-0001-7158-171X
  • Martínez, Cristina|||0000-0002-9368-1356
  • Vicario Perez, Maria|||0000-0001-9622-3185
Eosinophils are innate immune granulocytes actively involved in defensive responses and in local and systemic inflammatory processes. Beyond these effector roles, eosinophils are fundamental to maintaining homeostasis in the tissues they reside. Gastrointestinal eosinophils modulate barrier function and mucosal immunity and promote tissue development through their direct communication with almost every cellular component. This is possible thanks to the variety of receptors they express and the bioactive molecules they store and release, including cytotoxic proteins, cytokines, growth factors, and neuropeptides and neurotrophines. A growing body of evidence points to the eosinophil as a key neuro-immune player in the regulation of gastrointestinal function, with potential implications in pathophysiological processes. Eosinophil-neuron interactions are facilitated by chemotaxis and adhesion molecules, and the mediators released may have excitatory or inhibitory effects on each cell type, with physiological consequences dependent on the type of innervation involved. Of special interest are the disorders of the brain-gut interaction (DBGIs), mainly functional dyspepsia (FD) and irritable bowel syndrome (IBS), in which mucosal eosinophilia and eosinophil activation have been identified. In this review, we summarize the main roles of gastrointestinal eosinophils in supporting gut homeostasis and the evidence available on eosinophil-neuron interactions to bring new insights that support the fundamental role of this neuro-immune crosstalk in maintaining gut health and contributing to the pathophysiology of DBGIs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels, a longitudinal study and meta-analysis

  • Yeung, Edwina H.
  • Guan, Weihua
  • Zeng, Xuehuo
  • Salas, Lucas A.
  • Mumford, Sunni L.
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Van Meel, Evelien R.
  • Malmberg, Anni
  • Sunyer, Jordi
  • Duijts, Liesbeth
  • Felix, Janine F.|||0000-0002-9801-5774
  • Czamara, Darina
  • Hämäläinen, Esa
  • Binder, Elisabeth B.
  • Raïkkönen, Katri|||0000-0003-3124-3470
  • Lahti, Jari|||0000-0002-4310-5297
  • London, Stephanie J.|||0000-0003-4911-5290
  • Silver, Robert M.
  • Schisterman, Enrique F.
Background: Prenatal inflammation has been proposed as an important mediating factor in several adverse pregnancy outcomes. C-reactive protein (CRP) is an inflammatory cytokine easily measured in blood. It has clinical value due to its reliability as a biomarker for systemic inflammation and can indicate cellular injury and disease severity. Elevated levels of CRP in adulthood are associated with alterations in DNA methylation. However, no studies have prospectively investigated the relationship between maternal CRP levels and newborn DNA methylation measured by microarray in cord blood with reasonable epigenome-wide coverage. Importantly, the timing of inflammation exposure during pregnancy may also result in different effects. Thus, our objective was to evaluate this prospective association of CRP levels measured during multiple periods of pregnancy and in cord blood at delivery which was available in one cohort (i.e., Effects of Aspirin in Gestation and Reproduction trial), and also to conduct a meta-analysis with available data at one point in pregnancy from three other cohorts from the Pregnancy And Childhood Epigenetics consortium (PACE). Secondarily, the impact of maternal randomization to low dose aspirin prior to pregnancy on methylation was assessed. Results: Maternal CRP levels were not associated with newborn DNA methylation regardless of gestational age of measurement (i.e., CRP at approximately 8, 20, and 36 weeks among 358 newborns in EAGeR). There also was no association in the meta-analyses (all p.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Acute stress triggers sex-dependent rapid alterations in the human small intestine microbiota composition

  • Rodiño Janeiro, Bruno Kotska
  • Khannous, Olfat
  • Pigrau Pastor, Marc
  • Willis, Jesse R.
  • Pardo Camacho, Cristina
  • Albert Bayo, Mercé
  • Martínez Martínez, Cristina
  • lobo, beatriz
  • Santos, Javier
  • Salvo Romero, Eloisa
  • Nieto Ruiz, Adoración
  • Expósito , Elba
  • Fortea, Marina
  • González Castro, Ana Maria
  • Guagnozzi, Danila
  • Vicario Perez, Maria
  • Alonso Cotoner, Carmen
Irritable bowel syndrome; Small intestine microbiota; Stress, Síndrome del intestino irritable; Microbiota del intestino delgado; Estrés, Síndrome de l'intestí irritable; Microbiota de l'intestí prim; Estrès, Background/aims: Digestive disorders of gut-brain interaction (DGBI) are very common, predominant in females, and usually associated with intestinal barrier dysfunction, dysbiosis, and stress. We previously found that females have increased susceptibility to intestinal barrier dysfunction in response to acute stress. However, whether this is associated with changes in the small bowel microbiota remains unknown. We have evaluated changes in the small intestinal microbiota in response to acute stress to better understand stress-induced intestinal barrier dysfunction. Methods: Jejunal biopsies were obtained at baseline and 90 min after cold pain or sham stress. Autonomic (blood pressure and heart rate), hormonal (plasma cortisol and adrenocorticotropic hormone) and psychological (Subjective Stress Rating Scale) responses to cold pain and sham stress were monitored. Microbial DNA from the biopsies was analyzed using a 16S metabarcoding approach before and after cold pain stress and sham stress. Differences in diversity and relative abundance of microbial taxa were examined. Results: Cold pain stress was associated with a significant decrease in alpha diversity (P = 0.015), which was more pronounced in females, along with significant sex differences in the abundance of specific taxa and the overall microbiota composition. Microbiota alterations significantly correlated with changes in psychological responses, hormones, and gene expression in the intestinal mucosal. Cold pain stress was also associated with activation of autonomic, hormonal and psychological response, with no differences between sexes. Conclusions: Acute stress elicits rapid alterations in bacterial composition in the jejunum of healthy subjects and these changes are more pronounced in females. Our results may contribute to the understanding of female predominance in DGBI., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by Fondo Europeo de Desarrollo Regional (FEDER), Fondo de Investigación Sanitaria and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), y de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad y Ministerio de Ciencia e Innovación: EII2011-0035, CD15/00010 and MV17-00043 (BR-J); CM10/00155 (MP); FI12/00254 (ES-R); FI20/00256 (MA-B); CP18/00116 (CM); PI19/01643 (BL); PI16/00583, PI19/01643 and CPII16/00031 (MV); PI17/0190 (JS); INB Grant PT17/0009/0023 (TG); PI15/00301 (CA-C); CIBEREHD CB06/04/0021 (AG-C, DG, BL, MV, JS, CA-C); CIBERINFEC CB21/13/00061 (TG). Vall d'Hebron Institut de Recerca, Programa de becas predoctorales Amics de Vall d'Hebron: PRED-VHIR-2014-018 (MF), PRED-VHIR-2016-53 (CP-C). Ajuts per a la contractació de personal investigador FI, Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya: 2020FI_B1 00127 & 2019FI_B 00817 (MA-B), SGR423 (TG). Formación de profesorado universitario (FPU) program from the Spanish Ministerio de Universidades: FPU2020-02907 (OK-L). European Union's Horizon 2020 research and innovation program: ERC-2016-724173 (TG). Gordon and Betty Moore Foundation: GBMF9742 (TG).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Relationship between soluble urokinase-type plasminogen activator receptor and serum biomarkers of endothelial activation in patients with idiopathic nephrotic syndrome

  • Roca, Neus
  • Jatem-Escalante, Elias
  • Martin, Maria Luisa
  • Muñoz López, Marina
  • Molina, Maria
  • Martínez, Cristina
Biomarcadors; Activació endotelial; Síndrome nefròtica, Biomarcadores; Activación endotelial; Síndrome nefrótico, Biomarkers; Endothelial activation; Nephrotic syndrome, Background Serum levels of soluble urokinase-type plasminogen activator receptor (suPAR) are high in some patients with idiopathic nephrotic syndrome (INS). Given that suPAR constitutes a predictor of vascular disease and has been associated with endothelial dysfunction, we hypothesized that suPAR levels are related to endothelial activation or dysfunction in INS patients. The aims of this study were to evaluate the relationship between serum concentrations of endothelial biomarkers and suPAR in patients with different histological patterns of INS and healthy controls, and to determine the demographic, clinical and biochemical characteristics of INS patients that influence suPAR serum levels. Methods This observational, cross-sectional study included patients with INS, diagnosed with minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS) or membranous nephropathy (MN) by renal biopsy. Patient demographic, clinical and biochemical characteristics were recorded and blood samples were obtained at the time of diagnosis. Measurements of suPAR and endothelial molecules via serum levels were performed using Enzyme-Linked ImmunoSorbent Assay kits. Results Patients with nephrotic syndrome (n = 152) caused by FSGS, MCD or MN had increased circulating levels of endothelial markers. suPAR levels positively correlated with age and the serum levels of almost all endothelial markers. Generally, endothelial cell molecules positively correlated with each other. suPAR levels were not associated with the histopathological pattern of INS. Conclusions In patients with INS secondary to FSGS, MCD and NM, circulating levels of suPAR are independent of the primary renal disease, and significantly associated with age, glomerular filtration rate and the levels of various endothelial markers., C.M. is supported by a Miguel Servet grant, Fondo de investigación sanitaria, Instituto de Salud Carlos III, Ministerio de Ciencia, Innovación y Universidades, CP18/00116. No additional funding was required in the development of the current study